Vincent D D'Andrea, Kevin Melnick, Kendrick Yim, John Ernandez, Nnamdi Onochie, Timothy N Clinton, Graeme S Steele, Mark A Preston, Adam S Kibel, Matthew Mossanen
Radical cystectomy (RC) is an integral part of the management of patients with advanced-stage bladder cancer. This major oncologic operation is prone to complications resulting in morbidity and mortality. We analyzed the critical steps of open RC, performed an evidence-based review of these steps, and discussed our experience and approach. We conducted a literature review of the open RC technique, identified the critical steps that consistently appeared across different sources, and organized these steps into a framework. PubMed was queried with the critical steps as keywords for relevant articles published from 1 January 2013 to 1 August 2023. We utilized this query to conduct a systematic review of the literature using the outcomes of overall survival and 90-day complication rate. We developed the "Summary for the 10 Critical Operative Steps of Radical Cystectomy", a concise guide to the approach to open RC. When available, an evidence-based analysis of each critical step was performed. We also included additional components of cystectomy optimization such as pre-habilitation in the preoperative phase, standard versus extended lymphadenectomy, the vaginal-sparing approach to female radical cystectomy, patient-reported outcomes following urinary diversion, the use of a mesh for stoma formation, and the use of the ERAS protocol for postoperative care. An evidence-based assessment of RC may help provide valuable information to optimize surgical techniques and patient outcomes.
Eur Urol. 2020 Jan;77(1):55-65
[PMID:
31473012]
Lancet. 2015 Mar 14;385(9972):966-76
[PMID:
25784347]
BJU Int. 2015 May;115(5):713-21
[PMID:
24674655]
JAMA Oncol. 2015 Dec;1(9):1282-90
[PMID:
26448641]
Eur Urol. 2015 Jun;67(6):1042-1050
[PMID:
25496767]
Eur Urol. 2020 Jan;77(1):110-118
[PMID:
31740072]
Eur Urol. 2018 Oct;74(4):465-471
[PMID:
29784190]
Urol Oncol. 2023 Feb;41(2):108.e19-108.e27
[PMID:
36404231]
BMC Surg. 2022 Mar 29;22(1):118
[PMID:
35351086]
Eur Urol. 2010 Feb;57(2):196-201
[PMID:
19853987]
Nat Rev Dis Primers. 2017 Apr 13;3:17022
[PMID:
28406148]
CA Cancer J Clin. 2018 Nov;68(6):394-424
[PMID:
30207593]
Lancet. 2018 Jun 23;391(10139):2525-2536
[PMID:
29976469]
Eur Urol. 2023 Aug;84(2):176-190
[PMID:
37198015]
BJU Int. 2014 May;113(5):726-32
[PMID:
24053658]
JCO Glob Oncol. 2021 Sep;7:1547-1555
[PMID:
34767463]
Eur Urol. 2014 Aug;66(2):265-72
[PMID:
24630419]
Eur Urol. 2022 Mar;81(3):294-304
[PMID:
34629182]
Curr Urol. 2018 Jun;11(4):175-181
[PMID:
29997459]
J Clin Oncol. 2004 Jul 15;22(14):2781-9
[PMID:
15199091]
JAMA. 2022 Jun 7;327(21):2092-2103
[PMID:
35569079]
Eur Urol. 2020 Nov;78(5):757-763
[PMID:
32800407]
Eur Urol. 2016 Apr;69(4):613-621
[PMID:
26272237]
World J Surg Oncol. 2019 Dec 21;17(1):225
[PMID:
31864368]
Eur Urol Focus. 2021 Jan;7(1):132-138
[PMID:
31186173]
Res Rep Urol. 2021 Jul 29;13:535-547
[PMID:
34350137]
CA Cancer J Clin. 2023 Jan;73(1):17-48
[PMID:
36633525]
Clin Genitourin Cancer. 2022 Feb;20(1):60-68
[PMID:
34896022]
Eur Urol. 2019 Apr;75(4):604-611
[PMID:
30337060]